Mastitis is an inflammation of the breast that may, or may not, be due to infection. Mastitis is caused by a blockage (of milk) in the ducts of the breast. It occurs during the first months following childbirth. It is a common and painful problem for up to one third of all breastfeeding women. 

A milk duct can become blocked by a mass of thickened milk. The block is often   one-sided. A blocked duct presents as a painful, swollen, firm mass in the breast. Most often the woman is well but some feeling of sickness can be present. A blocked duct can cause slight fever and is often caused by the exposure to a draft, incomplete emptying of a duct during feeding or pressure e.g. from a tight bra. 

A blocked duct can go on to become mastitis. Mastitis can be inflammatory or may be due to an infection, most often caused by staphylococci. An infected mastitis can appear without a prior blocked duct if bacteria gains access to the breast through a crack or sore in the nipple. Symptoms can appear suddenly and the woman can feel very sick. It can be difficult to determine if the mastitis is infected and antibiotics are often given as a preventive measure. The difference between blocked ducts and mastitis is primarily that mastitis is associated with high fever, 39-40° C, eventually needing medical care. 

Abscess, pusing, occasionally complicates mastitis. Usually the woman’s state will improve and fever go down. The infected area is soft but the pus under the skin can be felt and if pressure is applied an indentation will remain. The breast will be severely painful and can be tense and glazed. Abscess should always be looked at by a doctor.

Clinical studies

Expected treatment outcome

A positive treatment effect with Salovum® can normally be seen within a few hours.

After termination of the AF products, a reduced effect can be noticed after a few weeks. If treatment is resumed, AF levels will rise within a matter of days, indicating a biological memory for AF production. 

Salovum® is the recommended AF treatment for patients who have difficulties eating large amounts of SPC-Flakes®. Studies also indicate that patients not responding to treatment with SPC-Flakes® may respond to Salovum®

For seriously ill patients or in patients with suspected low AF-levels, treatment with Salovum® quickly raises AF-levels directly in the intestine. Most often the patients initially treated with Salovum® can thereafter be transferred to the AF-inducing SPC-Flakes® in order to stimulate the body’s own production of AF.


The normal dosage of Salovum® is 4 g three times daily. The powder is blended with a cold liquid, e.g juice or water, preferably using a whisk or a blender. 

To stimulate the endogenous production of AF it is favourable to introduce AF inducing cereals, SPC-Flakes®, during treatment with, or as a follow-up treatment towards the end to, Salovum®.

Side effects, interactions and precautions

AF products have been eaten by tens of thousands of individuals and no side effects of medical nature have been reported. A few patients have experienced occasional constipation, but this discomfort can be reduced by a step-by-step introduction of the treatment. 

There are no reported interactions with concomitant medications. This is of importance as the patients should continue with their regular medical treatment. Salovum® should not replace or change the patients’ current medication. Persons with allergy to eggs should not be treated with Salovum®.

Where to buy, Prescriptions

Salovum® can be bought prescription free in pharmacies. As of December 31, 2010, Läkemedelsverket (The Medical Products Agency) has decided to include Salovum® and SPC-Flakes® in the new revised list for food for particular nutritional use for children under 16 years of age  and the cost will thus be included within the national benefit scheme for prescription drugs.

For patients 16 years of age or older, dieticians and most doctors can prescribe Salovum® as “sär-när”, foods for particular nutritional uses certified by the National Food Administration (Livsmedelsverket). The cost of the products varies between the different counties (landsting). 

Sweden: The pharmacies may not have Salovum® in stock, but they can in that case order it within 1-2 days. The reference number (varunummer) for Salovum is 21 06 81 .

Norway: In Norway, both SPC-Flakes® and Salovum® can be prescribed by physicians (blå resept), see links, [] []. and link to the Product Catalogue (p 8, Spesialløsninger) [] Salovum® can also be ordered from Poa Pharma Scandinavia AB, see link  

Denmark: Salovum® can be ordered from Poa Pharma Scandinavia AB, see link  

Finland: Salovum® can be ordered from Poa Pharma Scandinavia AB, see link